Publications and communications of Nadège Dubois

Abensur Vuillaume, L., Goffoy, J., Dubois, N., Almoyner, N., Bardet, C., Dubreucq, E., Klenkenberg, S., Donneau, A.-F., Dib, C., Ghuysen, A., & On Behalf Societe Francophone de Pédagogie Innovante en Santé and Medical Simulation Center of ULiège. (19 April 2024). Collaborative virtual reality environment in disaster medicine: moving from single player to multiple learners. BMC Medical Education, 24 (1), 422. doi:10.1186/s12909-024-05429-8

Abraham, P., Dubois, N., Rimmelé, T., Lilot, M., & Balança, B. (2024). Enhancing perioperative care through decontextualized simulation: A game-changer for non-technical skills training. Journal of Clinical Anesthesia. doi:10.1016/j.jclinane.2024.111428

Gaspar, A.* , Delwaide, A.-L.* , Ghuysen, A., Dubois, N., Herné, P., Lecomte, F., & Philippe, G. (2024). Development and evaluation of a simulation-based vaccination training course targeting vaccine hesitancy for pharmacy students [Paper presentation]. CIRM day, Belgium.
* These authors have contributed equally to this work.

Gaspar, A., Delwaide, A.-L., Ghuysen, A., Dubois, N., Herné, P., Lecomte, F., & Philippe, G. (2024). Development and evaluation of a simulation-based vaccination training course and evaluation of a simulation-based vaccination training course targeting vaccine hesitancy for pharmacy students [Paper presentation]. CIRM day, Belgium.

Delwaide, A.-L., Gaspar, A., Dubois, N., Ghuysen, A., Lallemand, A., Lecomte, F., & Philippe, G. (24 August 2023). Impacts of a simulation-based vaccination training course on master's degree students in pharmacy. Pharmacy Education, 23 (5), 1-38. doi:10.46542/pe.2023.235.138

Delwaide, A.-L., Gaspar, A., Dubois, N., Ghuysen, A., Lallemand, A., Lecomte, F., & Philippe, G. (04 July 2023). Impacts of a simulation-based vaccination training course on master’s degree students in pharmacy [Paper presentation]. FIP Pharmacy Practice Research summer meeting, Granada, Spain.

Dubois, N., Berendsen, S., Tan, K., Schoysmans, L., Spliet, W., Seute, T., Bours, V., & Robe, P. (October 2022). STAT5b is a marker of poor prognosis, rather than a therapeutic target in glioblastomas. International Journal of Oncology, 61 (4). doi:10.3892/ijo.2022.5414

PAQUAY, M., Dubois, N., Diep, A. N., Graas, G., Sassel, T., PIAZZA, J., Servotte, J.-C., & GHUYSEN, A. (24 June 2022). “Debriefing and Organizational Lessons Learned” (DOLL): A Qualitative Study to Develop a Classification Framework for Reporting Clinical Debriefing Results. Frontiers in Medicine, 9. doi:10.3389/fmed.2022.882326

Dubois, N., Diep, A. N., Ghuysen, A., Declaye, J., Donneau, A.-F., Vogin, G., Fleckenstein, J., Coucke, P., & Ben Mustapha, S. (22 June 2022). Training of radiotherapy professionals: status, content, satisfaction and improvement suggestions in the Greater Region. BMC Medical Education, 22 (1), 485. doi:10.1186/s12909-022-03567-5

BEN MUSTAPHA, S., Simoni, P., DUBOIS, N., JANSEN, N., Lakosi, F., Silva Mota, A., Ramella, S., & COUCKE, P. (March 2022). The COVID-19 Status of Patients Is an Essential Determinant for Decision-Making by Radiation Oncologists: A European Survey. Cureus, 14 (3), 22842. doi:10.7759/cureus.22842

Chevalier, S., & Dubois, N. (2021). Impact of virtual reality training in disaster medicine. Archives of Public Health.

PAQUAY, M., BOULANGER, J.-M., LOCQUET, M., Dubois, N., & GHUYSEN, A. (2021). Exploring the feasibility of the Magnet Hospital concept within a European university nursing department: a mixed-methods study. Contemporary nurse. doi:10.1080/10376178.2021.1987939

DUBOIS, N., CUCCHIARO, S., BEN MUSTAPHA, S., NOEL, M., RUYANGE, B. W., Ghuysen, A., Bragard, I., & COUCKE, P. (2019). Simulation-based training development to strive for excellence in radiation oncologist's education. Archives of Public Health.

DUBOIS, N., Berendsen, S., HENRY, A., Nguyen, M., Bours, V., & Robe, P. A. (26 February 2018). I-Kappa-B kinase-epsilon activates nuclear factor-kappa B and STAT5B and supports glioblastoma growth but amlexanox shows little therapeutic potential in these tumors. Cancer Translational Medicine, 4 (1), 1-8. doi:10.4103/ctm.ctm_3_18

Dubois, N., Willems, M., Kroonen, J., Berendsen, S., Van Hecke, W., Bredel, M., Poulet, C., Chakravarti, A., Bours, V., & Robe, P. (29 November 2016). Involvement of Ikbζ in glioblastomas and its potential implication in radioresistance [Poster presentation]. 28th EORTC-NCI-AACR symposium on "Molecular targets and cancer therapeutics", Munich, Germany.

Dubois, N., Willems, M., Kroonen, J., Berendsen, S., Van Hecke, W., Bredel, M., Musumeci, L., Poulet, C., Chakravarti, A., Bours, V., & Robe, P. (09 September 2016). Involvement of Ikbζ in glioblastomas and its potential implication in radioresistance [Poster presentation]. Annual Mini Symposium - EDT-Cancérologie Expérimentale, Bruxelles, Belgium.

Karim, R., Palazzo, C., Dubois, N., Bours, V., Passirani, C., & Evrard, B. (April 2016). Development of injectable liposomes entrapping apigenin for brain-targeted delivery as glioblastoma treatment [Poster presentation]. 10th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.

Dubois, N., Willems, M., Kroonen, J., Berendsen, S., Van Hecke, W., Bredel, M., Musumeci, L., Poulet, C., Chakravarti, A., Bours, V., & Robe, P. (2016). Involvement of Ikbζ in glioblastomas and its potential implication in radioresistance [Poster presentation]. 28th EORTC-NCI-AACR symposium on "Molecular targets and cancer therapeutics", Munich, Germany.

Dubois, N., Willems, M., Nguyen-Khac, M.-T., Kroonen, J., Goffart, N., Deprez, M., Bours, V., & Robe, P. (2016). Constitutive activation of casein kinase 2 in glioblastomas: Absence of class restriction and broad therapeutic potential. International Journal of Oncology, 48 (6), 2445-52. doi:10.3892/ijo.2016.3490

Willems, M., Dubois, N., Musumeci, L., Bours, V., & Robe, P. (2016). IkappaBzeta: an emerging player in cancer. Oncotarget, 7 (40), 66310-66322. doi:10.18632/oncotarget.11624

Karim, R., Palazzo, C., Dubois, N., Bours, V., Passirani, C., Evrard, B., & Piel, G. (08 September 2015). Stealth Liposome and Drug-In-Cyclodextrin-In-Liposome Formulations Entrapping Apigenin as Novel Therapy for Glioblastoma [Poster presentation]. 'From drug development to target drug'- UniGR workshop on Biomedicine, Arlon, Belgium.

Karim, R., Palazzo, C., Dubois, N., Bours, V., Passirani, C., & Piel, G. (17 April 2015). Liposomes entrapping apigenin for the treatment of glioblastoma [Poster presentation]. 2015 UKICRS Workshop & Symposium, Nottingham, United Kingdom.

Karim, R., Palazzo, C., Dubois, N., Bours, V., Passirani, C., & Piel, G. (14 April 2015). PEGylated liposomes containing apigenin for the treatment of glioblastoma [Poster presentation]. 1st European conference on Pharmaceutics Reims 2015, Reims, France.

Karim, R., Palazzo, C., Dubois, N., Frère, A., Bours, V., Passirani, C., Evrard, B., & Piel, G. (2015). Design of Liposomes Entrapping Apigenin- A Novel Approach for Glioblastoma Therapy [Poster presentation]. 2015 AAPS Annual Meeting and Exposition, Orlando, United States.